Geneos is a Pennsylvania-based clinical-stage biotechnology company that researches and develops tumor neoantigen-targeted immunotherapies for the treatment of cancer... Read more
Geneos is a Pennsylvania-based clinical-stage biotechnology company that researches and develops tumor neoantigen-targeted immunotherapies for the treatment of cancer... Read more
News
Apr 09, 2024
Pharmabiz
Geneos Therapeutics: Geneos announces positive phase 1/2 data for GT30 trial of personalized therapeutic cancer vaccine
Apr 08, 2024
Clinical Trials Arena
Geneos Therapeutics: Geneos' vaccine shows promise in hepatocellular carcinoma trial
Oct 05, 2023
Pulse2.0
Geneos Therapeutics: Geneos Therapeutics: Clinical-Stage Biotherapeutics Company Secures $5 Million
Sep 28, 2023
FinSMEs
Geneos Therapeutics: Geneos Therapeutics Closes $5M Series A3 Financing
Sep 28, 2023
The Business Journals: Philadelphia
Geneos Therapeutics: Inovio spinoff Geneos raises another $5M to advance therapeutic cancer vaccines
Aug 22, 2023
Endpoints News
Geneos: Geneos outlines new PhIb/IIa data in advanced liver cancer with alternative response measure
Aug 22, 2023
PR Newswire
Press Release: Geneos : Geneos Therapeutics Announces Eight of 34 Patients to Achieve Complete Response, Complete Molecular Response, or, Secondary Resectability in Ongoing Clinical Trial of Personalized Therapeutic Cancer Vaccination in Second Line Advanced Liver Cancer
Jul 28, 2023
PR Newswire
Press Release: Geneos : Geneos Therapeutics Nominated for 2023 Prix Galien USA Startup Award
Apr 12, 2023
FinSMEs
Geneos: Geneos Therapeutics Raises $5M in Series A3 Financing
Nov 07, 2022
PR Newswire
Press Release: Geneos : Geneos Therapeutics Announces Positive Clinical Data for Personalized Therapeutic Cancer Vaccines in Ongoing Liver Cancer Trial
Geneos Therapeutics Competitors
1
2
3
4
5
6
7
8
9